Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Change in Accured Expenses (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Change in Accured Expenses data on record, last reported at $14.4 million in Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 78.01% year-over-year to $14.4 million; the TTM value through Dec 2025 reached $11.2 million, down 30.48%, while the annual FY2025 figure was $11.2 million, 30.48% down from the prior year.
  • Change in Accured Expenses reached $14.4 million in Q4 2025 per PRAX's latest filing, up from $1.6 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $14.4 million in Q4 2025 and bottomed at -$8.3 million in Q1 2025.
  • Average Change in Accured Expenses over 4 years is $521750.0, with a median of $976000.0 recorded in 2023.
  • Peak YoY movement for Change in Accured Expenses: surged 2067.11% in 2024, then plummeted 1261.84% in 2025.
  • A 4-year view of Change in Accured Expenses shows it stood at -$2.0 million in 2022, then surged by 118.39% to $374000.0 in 2023, then soared by 2067.11% to $8.1 million in 2024, then skyrocketed by 78.01% to $14.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $14.4 million in Q4 2025, $1.6 million in Q3 2025, and $3.5 million in Q2 2025.